Nara, Japan

Satoru Hirabayashi

This inventor holds 1 USPTO granted patent. Top assignees: Hagihara Farm Production Institute Co., Ltd., Kinki University, Mie University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satoru Hirabayashi. Retrieved from https://idiyas.com/inventor/satoru-hirabayashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Satoru Hirabayashi: Innovator in Cancer Research

Introduction

Satoru Hirabayashi is a notable inventor based in Nara, Japan. He has made significant contributions to the field of cancer research, particularly in developing compositions that inhibit cancer cell growth. His innovative work has the potential to impact cancer treatment and prevention.

Latest Patents

Hirabayashi holds 1 patent for a cancer cell growth inhibiting composition. This composition includes compounds that demonstrate a higher efficacy in inhibiting cancer cell growth compared to phytol, which is derived from watermelon sprouts. The invention addresses the challenge of the large amounts of phytol required for effective cancer cell growth inhibition.

Career Highlights

Throughout his career, Satoru Hirabayashi has worked with reputable organizations, including Hagihara Farm Production Institute Co., Ltd. and Mie University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Hirabayashi has collaborated with esteemed colleagues such as Takashi Kitayama and Toshiharu Hashizume. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.

Conclusion

Satoru Hirabayashi's innovative work in cancer research exemplifies the importance of scientific advancements in healthcare. His contributions have the potential to lead to more effective cancer treatments and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…